Sastasundar Ventures Limited (SASTASUNDR) AI Stock Analysis

• Market Cap: ₹9.92B
• Dividend Yield: N/A
• Average Volume (3M): 16.73K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.02
• Revenue Growth: -14.64%
• EPS Growth: -355.03%
• Country: IN
• Employees: 941
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 7.52
• Shares Outstanding: 31,810,500
• 10 Day Avg. Volume: 48,733
• 30 Day Avg. Volume: 16,730
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹284.00
• Price Target Upside: -8.67% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 47 Neutral
• Price Target: ₹284.00 ▼(-8.67% Downside)

The overall stock score of 47 reflects significant financial challenges, including declining revenues and persistent losses. Technical analysis shows neutral to bearish momentum, while valuation metrics are unattractive due to negative earnings. The absence of earnings call data and corporate events limits further insights.

Sastasundar Ventures Limited Business Overview & Revenue Model

Company Description

Sastasundar Ventures Limited operates a digital network of healthcare in India. It finances loans, and invests in shares and securities, as well as provides financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The company also operates sastasundar.com and retailershakti.com portal for pathology and healthcare products marketing activities, as well as provides diagnostic services, such as pathological/radiological investigations. In addition, it distributes medicines and wellness products; and provides customized heath supplements and diet counselling, as well as health information services. The company was formerly known as Microsec Financial Services Limited and changed its name to Sastasundar Ventures Limited in November 2016. Sastasundar Ventures Limited was incorporated in 1989 and is based in Kolkata, India.

How the Company Makes Money

Sastasundar Ventures Limited generates revenue through its e-commerce platform, which facilitates the sale of pharmaceutical and healthcare products directly to consumers. The company makes money by purchasing products from manufacturers or authorized distributors at wholesale prices and selling them at a retail margin. Additionally, Sastasundar may earn revenue from partnerships with healthcare providers, pharmacies, and wellness brands looking to reach a broader customer base through its platform. The company's business model focuses on efficiency in supply chain management and cost reduction to offer competitive pricing, thus attracting a larger customer base and driving sales growth.

Sastasundar Ventures Limited Financial Statement Overview

Summary

Sastasundar Ventures Limited faces financial challenges with declining revenues and persistent losses, impacting profitability. Despite a stable balance sheet with low debt, operational inefficiencies are evident through negative margins and cash flow issues. The company needs to improve cash generation and operational performance to enhance financial stability.

Income Statement

Sastasundar Ventures Limited has shown significant volatility in revenue and profitability. The company experienced a notable decline in revenue from 2024 to 2025, with a decrease from 13.56 billion to 10.89 billion. The net profit margin has been negative, reflecting recurring losses, with net income dropping from a modest profit in 2024 to a significant loss in 2025. The EBIT and EBITDA margins are also negative, indicating operational inefficiencies. A key strength is the prior year revenue growth between 2023 and 2024, but consistent profitability remains a challenge.

Balance Sheet

The company's balance sheet demonstrates moderate strength, with a favorable equity ratio due to a substantial stockholders' equity of 6.70 billion against total assets of 9.74 billion as of 2025. The debt-to-equity ratio is low, signifying minimal leverage, which reduces financial risk. However, the return on equity is negative due to net losses, indicating that the company is not effectively generating returns on its equity base.

Cash Flow

Cash flow analysis indicates challenges, with negative operating cash flow in 2025, pointing to struggles in generating cash from core operations. Free cash flow has also decreased significantly, reflecting negative growth and potential liquidity issues. Positive free cash flow from 2024 did not sustain, which impacts the company's ability to fund operations without external financing.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	11.04B	10.90B	13.56B	10.38B	6.30B	5.46B
Gross Profit	561.07M	721.21M	1.20B	711.54M	445.35M	513.28M
EBITDA	-1.76B	-1.87B	-203.51M	-1.13B	11.22B	-109.58M
Net Income	-887.63M	-911.67M	88.83M	-722.11M	6.27B	-104.01M
Balance Sheet
Total Assets	0.00	9.74B	11.50B	12.06B	12.78B	2.93B
Cash, Cash Equivalents and Short-Term Investments	250.79M	124.44M	665.40M	2.08B	2.12B	124.49M
Total Debt	0.00	9.19M	38.83M	93.25M	18.53M	152.02M
Total Liabilities	-8.92B	1.10B	1.50B	2.12B	1.84B	634.32M
Stockholders Equity	8.92B	6.70B	7.62B	7.53B	8.27B	2.00B
Cash Flow
Free Cash Flow	0.00	-276.65M	239.34M	-1.31B	-2.12B	-314.92M
Operating Cash Flow	0.00	-173.09M	381.65M	-1.12B	-2.07B	-305.08M
Investing Cash Flow	0.00	-11.34M	-339.27M	1.24B	2.20B	213.71M
Financing Cash Flow	0.00	-4.43M	-23.52M	-18.33M	-114.22M	37.26M

Sastasundar Ventures Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 310.95
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SASTASUNDR, the sentiment is Positive. The current price of 310.95 is above the 20-day moving average (MA) of 282.80, above the 50-day MA of 284.02, and above the 200-day MA of 279.24, indicating a bullish trend. The MACD of 7.02 indicates Negative momentum. The RSI at 63.35 is Neutral, neither overbought nor oversold. The STOCH value of 72.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SASTASUNDR.

Sastasundar Ventures Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MEDPLUS	62 Neutral	100.73B	56.37	8.64%	―	6.18%	134.11%
SASTASUNDR	47 Neutral	₹9.92B	―		―	-14.64%	-355.03%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Sastasundar Ventures Limited Corporate Events

Sastasundar Ventures Announces 36th AGM and E-Voting Details

Sastasundar Ventures Limited announced the publication of a newspaper notice regarding its 36th Annual General Meeting (AGM) and e-voting information. The notice was published in ‘Business Standard’ in English and ‘Ekdin’ in Bengali. This announcement is part of the company’s compliance with various regulatory requirements, ensuring transparency and communication with its stakeholders. The AGM will provide shareholders with an opportunity to participate in the company’s governance and decision-making processes through e-voting.

Sastasundar Ventures Ensures Shareholder Communication Compliance

Sastasundar Ventures Limited has announced the dispatch of letters to shareholders who have not registered their email addresses with the company or its agents. This initiative is part of compliance with SEBI regulations to ensure all shareholders receive the necessary information regarding the company’s 36th Annual General Meeting and the Annual Report for the financial year 2024-25. The company emphasizes the importance of updating KYC details and encourages shareholders to dematerialize physical securities to facilitate efficient communication and transactions.

Sastasundar Ventures Releases Investor Presentation

Sastasundar Ventures Limited has released an investor presentation, as per the requirements of SEBI’s Listing Obligations and Disclosure Regulations, 2015. This announcement is part of the company’s ongoing efforts to maintain transparency with stakeholders and provide updates on its strategic direction and financial health.